ワクチンが誘発する抗原結合ホットスポットを持つ抗体系は,広範囲のHIV中和を発展させる
Rui Kong1, Hongying Duan1, Zizhang Sheng2
1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Cell
|July 27, 2019
まとめ
HIV-1 融合ペプチド (FP) によるプライミングは,広範囲に中和する抗体 (bNAbs) を誘発する. これらの抗体は保存された領域を標的とし,様々なHIV-1株の中和を強化します.
科学分野:
- 免疫学
- ウイルス学
- ワクチン開発
背景:
- 様々なHIV-1株に対する広範な中和性抗体 (bNAbs) をワクチン接種を通じて誘発することは依然として重要な課題です.
- bNAbsを誘発するメカニズムの理解は,効果的なHIVワクチンの設計に不可欠です.
研究 の 目的:
- ワクチン接種されたマカクのHIV-1融合ペプチド (FP) を標的とした抗体系統を特定,特徴づけ,追跡する.
- FPによるプライミングが広範な中和抗体 (bNAbs) を誘導できるかどうかを判断する.
主な方法:
- マカクのワクチン接種は,FP キャリアコンストラクットとエンベロープ (Env) トリマーブーストで実施する.
- 抗体系統の遺伝子と構造分析
- 抗体発現と拡大を追跡するB細胞分析
- 様々なHIV-1株に対する抗体中和幅の評価
主要な成果:
- FPを標的とする5つの中和抗体 (Ab) 系統が特定され,追跡された.
- 2つの系統は複製可能な広範な中和性を示し,208種類のHIV-1株の59%に対して有効でした.
- FP-キャリアプライミングは5つの系統を起動し,拡張し,Env-トリマーブーストは交叉反応中和を誘導した.
- FP-プライミングによって誘発されたABSは,Env-trimerのみの免疫からのABSとは異なり,FPに焦点を当てた結合エネルギーホットスポットを示しました.
結論:
- HIV-1 FPのような保存された亜領域をプリミングすると,標的部位に結合エネルギーホットスポットを持つ抗体が誘発されます.
- このプライミング戦略は,様々なHIV-1株に対して広範な中和を可能にする抗体を導きます.
- FP向け bNAbsはHIVワクチン開発の有望な道を示しています.
関連する概念動画
Vaccinations
51.3K
Overview
51.3K
Antibody Structure
65.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
Nuclear Binding Energy
14.7K
The difference between the calculated and experimentally measured masses is known as the mass defect of the atom. In the case of helium-4, the mass defect indicates a “loss” in mass of 4.0331 amu – 4.0026 amu = 0.0305 amu. The loss in mass accompanying the formation of an atom from protons, neutrons, and electrons is due to the conversion of that mass into energy that is evolved as the atom forms. The nuclear binding energy is the energy produced when the atoms’ nucleons are bound...
14.7K
Acids, Bases and Neutralization Reactions
63.6K
An acid-base reaction is one in which a hydrogen ion, H+, is transferred from one chemical species to another. Such reactions are of central importance to numerous natural and technological processes, ranging from the chemical transformations within cells or lakes and oceans to the industrial-scale production of fertilizers, pharmaceuticals, and other substances essential to the society.
63.6K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K


